Prednisolone Sodium Phosphate Orally Disintegrating Tablets (Orapred ODT ® )

Abstract

Get full access to this article

View all access options for this article.

References

Prednisolone sodium phosphate (Orapred ODT^®) orally disintegrating tablet [package insert]. Atlanta, GA: Sciele Pharma, Inc; 1996.

US Food and Drug Administration. FDA Orange Book Online. Prednisolone sodium phosphate (Orapred ODT^®). http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=021959&TABLE1=OB_Rx . Accessed February 23, 2010.

US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2007. NIH Publication No. 07-4051. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf .

US Food and Drug Administration. FDA Warning Letter. Biomarin Pharmaceutical Inc. October 11, 2006. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2006/ucm076093.htm . Accessed February 23, 2010.